News & Updates

Rescue therapy using the Janus kinase 1 inhibitor abrocitinib combined with topical medicated therapy recaptured efficacy responses and had a favourable safety profile in individuals with moderate-to-severe atopic dermatitis (AD) who experienced flare during the maintenance period of the phase III randomized-withdrawal JADE REGIMEN trial.

Strong family resilience may help lessen the psychological consequences of the coronavirus disease 2019 (COVID-19), according to a recent Singapore study.

Treatment with intravenous brivaracetam is well tolerated in children with epilepsy, with a safety profile consistent with that known of the oral formulation, according to the results of a phase II study. There has been no pharmacokinetic difference observed when administered as bolus or a 15-minute infusion.

The Omicron variant of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is more stable than the ancestral strain on various smooth and porous surfaces and demonstrates marked resistance to neutralizing monoclonal antibodies (mAbs), researchers from the University of Hong Kong (HKU) have reported.

Eating fish can reduce the risk of stroke, but the benefit is dictated by how fish is prepared and how often it is consumed, according to a study. Specifically, frequent consumption of baked or broiled fish is protective while regular consumption of fried fish contributes to a risk increase, which differs by socioeconomic status.

Implementation of an inpatient pancreatitis service appears to result in better outcomes in patients with mild acute pancreatitis, suggests a study. Guideline-based educational interventions deliver benefits on the management of this condition by admitting teams even without pancreatitis consultation.

Older adults in long-term care facilities see a rapid drop in antibody titres over the first 6 months after the second dose of the BNT162b2 vaccine for the coronavirus disease 2019 (COVID-19), reports a recent study.